Everything Ends’ Post

JUST OUT! The report of a new perspective to innovate assessment of the potency of cell therapy products. https://lnkd.in/gQfWjsmZ

Part 2 of our article about "particular" problems with cell therapy products is now online. Looking forward to discussing it with you! https://lnkd.in/ezEJjZsA

While this is a streamlined process, the constantly evolving landscape of cell therapy manufacturing innovations is beginning to see faster and more efficient approaches

Curious to know how Kite Pharma is breaking manufacturing bottlenecks to enhance access to life-saving CAR T-cell therapies? Dive into insights from our August webinar featuring Laura Alquist on overcoming challenges in autologous cell therapy production. Read more: https://hubs.ly/Q02PSBXp0 #CellTherapy #Biotech #HealthcareInnovation

Cell clumps and particles are serious challenges in cell therapy, impacting safety and efficacy. Part 2 of Cell and Gene’s recent article takes a close look at these issues. That’s why we built the Aura system to tackle them head-on. Aura provides high-resolution imaging to automatically detect and analyze cell clumps, aggregates, and other inherent particles, making it easier to meet quality and regulatory standards. Read more: https://lnkd.in/ezEJjZsA  

What tools are right for decentralized cell therapy setups? Josh Ludwig tackles equipment selection, digital solutions, and overcoming those unique hurdles in a recent Phacilitate panel: https://lnkd.in/eZca_ZYD #celltherapy #GMP #futureofmedicine

Understanding the key ingredients to bring your cell therapy to market is crucial to achieving success. By starting with the end result in mind, you can avoid late phase CGT challenges. Discover how we helped 35+ global cell therapy clients. https://okt.to/3JDfPC #celltherapymanufacturing #cdmo #cgt

Understanding the key ingredients to bring your cell therapy to market is crucial to achieving success. By starting with the end result in mind, you can avoid late phase CGT challenges. Discover how we helped 35+ global cell therapy clients. https://okt.to/ueHjTb #celltherapymanufacturing #cdmo #cgt

Understanding the key ingredients to bring your cell therapy to market is crucial to achieving success. By starting with the end result in mind, you can avoid late phase CGT challenges. Discover how we helped 35+ global cell therapy clients. https://okt.to/1tBEXi #celltherapymanufacturing #cdmo #cgt

Understanding the key ingredients to bring your cell therapy to market is crucial to achieving success. By starting with the end result in mind, you can avoid late phase CGT challenges. Discover how we helped 35+ global cell therapy clients. https://okt.to/gIiRfB #celltherapymanufacturing #cdmo #cgt